David Y. Liu
Net worth: 4 M $ as of 2024-03-30
Profile
David Y.
Liu was the founder of Trenovus, Inc. (founded in 2010) where he held the title of Chief Operating Officer from 2010 to 2012.
He previously worked at Scios, Inc. from 1992 to 2002 as Director-Inflammation Research and at FibroGen, Inc. from 2002 to 2010 as Vice President-Research.
Dr. Liu also worked at Harvard Medical School from 1976 to 1986 as Assistant Professor-Medicine Department.
He is currently the Chief Research & Development Strategy Officer at Protagonist Therapeutics, Inc. (since 2013).
Dr. Liu holds a doctorate degree from Michigan State University and an undergraduate degree from The University of Chicago.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-03-14 | 144,687 ( 0.25% ) | 4 M $ | 2024-03-30 |
Former positions of David Y. Liu
| Companies | Position | End |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
| Trenovus, Inc. | Founder | 2011-12-31 |
| FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 2009-12-31 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 2001-12-31 |
| Harvard Medical School | Corporate Officer/Principal | 1985-12-31 |
Training of David Y. Liu
| Michigan State University | Doctorate Degree |
| The University of Chicago | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
| Trenovus, Inc. |
- Stock Market
- Insiders
- David Y. Liu
